This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2024 Jan;99(1):4-6.

doi: 10.1016/j.mayocp.2023.11.014.

Generic Tofacitinib-A More Affordable JAK Inhibitor

Guro L Goll¹, Tore K Kvien²

Affiliations

Affiliations

¹ Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway; Institute of Health and Society, University of Oslo, Oslo, Norway.
² Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Electronic address: t.k.kvien@medisin.uio.no.

PMID: 38176834
DOI: 10.1016/j.mayocp.2023.11.014

Editorial

Generic Tofacitinib-A More Affordable JAK Inhibitor

Guro L Goll et al. Mayo Clin Proc. 2024 Jan.

. 2024 Jan;99(1):4-6.

doi: 10.1016/j.mayocp.2023.11.014.

Authors

Guro L Goll¹, Tore K Kvien²

Affiliations

¹ Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway; Institute of Health and Society, University of Oslo, Oslo, Norway.
² Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Electronic address: t.k.kvien@medisin.uio.no.

PMID: 38176834
DOI: 10.1016/j.mayocp.2023.11.014

No abstract available

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science